Fingerprint
Dive into the research topics of 'A phase II study of the survivin suppressant YM155 in patients with refractory diffuse large B-cell lymphoma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
A phase II study of the survivin suppressant YM155 in patients with refractory diffuse large B-cell lymphoma
Bruce D. Cheson, Nancy L. Bartlett, Julie M. Vose, Andres Lopez-Hernandez, Amanda L. Seiz, Anne T. Keating, Setareh Shamsili
Research output: Contribution to journal › Article › peer-review
102
Scopus
citations